Close Menu
Home » Sera Prognostics Closes $20M Series B Financing Round

Sera Prognostics Closes $20M Series B Financing Round

Jan 07, 2015
|
staff reporter

NEW YORK(GenomeWeb) – Sera Prognostics said today it has closed $20 million in Series B financing.

The round was led by European investment firm Chione, which is a new investor in the firm, and included current Sera investors Domain Associates, InterWest Partners, Catalyst Health Ventures, UpStart Life Sciences Capital, and Osage University Partners.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Cleared the Committee

The Washington Post reports that a US Senate committee voted this week to approve the nomination of Stephen Hahn to lead the Food and Drug Administration.

Hope, But Cost Worries

Nature News reports that gene therapy approaches are tackling sickle cell disease, but that the cost of treatment is a concern.

One Gene to Shape the Face

One gene regulates hundreds of others to influence facial development, according to New Scientist.

Nature Studies Review Resources for Single-Cell Analysis, Examine ALS Exomes, More

In Nature this week: resources for single-cell analysis, little overlap in the microRNAs used by Salmonella and Shigella to infect host cells, and more.

What's Popular?

In Proteomics & Protein Research

  1. Akoya Biosciences Closes $50M Funding Round

  2. Alzheimer's Drug Discovery Foundation Awards $5.5M in Grants for Diagnostic Development

  3. Human Protein Atlas Team Maps Human Secretome

    Premium

  4. Canopy Biosciences Acquires Biopharma Services Firm Core Diagnostics

  5. SomaLogic's Protein Blood Test Shows Potential for Health Screening in Proof-of-Concept Study

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.